A DNA-nanoassembly-based approach to map membrane protein nanoenvironments

被引:31
作者
Ambrosetti, Elena [1 ]
Bernardinelli, Giulio [1 ]
Hoffecker, Ian [1 ]
Hartmanis, Leonard [2 ]
Kiriako, Georges [1 ]
de Marco, Ario [3 ]
Sandberg, Rickard [2 ]
Hogberg, Bjorn [1 ]
Teixeira, Ana, I [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden
[2] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden
[3] Univ Nova Gorica, Lab Environm & Life Sci, Nova Gorica, Slovenia
基金
瑞典研究理事会; 欧洲研究理事会;
关键词
HEREGULIN; HER2; EXPRESSION; INTEGRINS; GROWTH; ASSOCIATION; METASTASIS; SUFFICIENT; BIOLOGY;
D O I
10.1038/s41565-020-00785-0
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
A DNA-nanoassembly-based non-microscopy method is developed for ensemble analysis of membrane protein nanodomains. Most proteins at the plasma membrane are not uniformly distributed but localize to dynamic domains of nanoscale dimensions. To investigate their functional relevance, there is a need for methods that enable comprehensive analysis of the compositions and spatial organizations of membrane protein nanodomains in cell populations. Here we describe the development of a non-microscopy-based method for ensemble analysis of membrane protein nanodomains. The method, termed nanoscale deciphering of membrane protein nanodomains (NanoDeep), is based on the use of DNA nanoassemblies to translate membrane protein organization information into a DNA sequencing readout. Using NanoDeep, we characterized the nanoenvironments of Her2, a membrane receptor of critical relevance in cancer. Importantly, we were able to modulate by design the inventory of proteins analysed by NanoDeep. NanoDeep has the potential to provide new insights into the roles of the composition and spatial organization of protein nanoenvironments in the regulation of membrane protein function.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 63 条
[1]   Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator [J].
Andersson, Ken G. ;
Oroujeni, Maryam ;
Garousi, Javad ;
Mitran, Bogdan ;
Stahl, Stefan ;
Orlova, Anna ;
Lofblom, John ;
Tolmachev, Vladimir .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (06) :2285-2293
[2]  
Atlas E, 2003, MOL CANCER RES, V1, P165
[3]   Ionic effects on the elasticity of single DNA molecules [J].
Baumann, CG ;
Smith, SB ;
Bloomfield, VA ;
Bustamante, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6185-6190
[4]  
Beghin A, 2017, NAT METHODS, V14, P1184, DOI [10.1038/NMETH.4486, 10.1038/nmeth.4486]
[5]   Entirely enzymatic nanofabrication of DNA-protein conjugates [J].
Bernardinelli, Giulio ;
Hogberg, Bjorn .
NUCLEIC ACIDS RESEARCH, 2017, 45 (18)
[6]   Spatial organization of transmembrane receptor signalling [J].
Bethani, Ioanna ;
Skanland, Sigrid S. ;
Dikic, Ivan ;
Acker-Palmer, Amparo .
EMBO JOURNAL, 2010, 29 (16) :2677-2688
[7]   Bringing Microscopy-By-Sequencing into View [J].
Boulgakov, Alexander A. ;
Ellington, Andrew D. ;
Marcotte, Edward M. .
TRENDS IN BIOTECHNOLOGY, 2020, 38 (02) :154-162
[8]   Role of heregulin in human cancer [J].
Breuleux, M. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (18) :2358-2377
[9]   Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface [J].
Claus, Jeroen ;
Patel, Gargi ;
Autore, Flavia ;
Colomba, Audrey ;
Weitsman, Gregory ;
Soliman, Tanya N. ;
Roberts, Selene ;
Zanetti-Domingues, Laura C. ;
Hirsch, Michael ;
Collu, Francesca ;
George, Roger ;
Ortiz-Zapater, Elena ;
Barber, Paul R. ;
Vojnovic, Boris ;
Yarden, Yosef ;
Martin-Fernandez, Marisa L. ;
Cameron, Angus ;
Fraternali, Franca ;
Ng, Tony ;
Parker, Peter J. .
ELIFE, 2018, 7
[10]   Efficient Payload Delivery by a Bispecific Antibody-Drug Conjugate Targeting HER2 and CD63 [J].
de Goeij, Bart E. C. G. ;
Vink, Tom ;
ten Napel, Hendrik ;
Breij, Esther C. W. ;
Satijn, David ;
Wubbolts, Richard ;
Miao, David ;
Parren, Paul W. H. I. .
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) :2688-2697